Notice ID: f7ce7fa8105d4fb9977444970d785944Solicitation
NanoBret Kinase Assay
Archived on September 14, 2022. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 9:00 AM UTC−04:00
- Posted
- September 7, 2022
- Notice type
- Solicitation
- NAICS
- 541380: Testing Laboratories and Services
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NIDA
- Last updated
- Sep 9, 2025
Identifiers
- Solicitation number
- 75N95022Q00552
- Notice ID
- f7ce7fa8105d4fb9977444970d785944
Description
The National Center for Advancing Translational Sciences (NCATS) is a part of the NIH, with a mission to catalyze the generation of innovative methods and technologies that will enhance the development, testing, and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions. (NCATS) would like to acquire services from Reaction to test 100 compounds against select kinases in a cellular NanoBret Assay.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75N95022Q00552- Solicitation
Award typically follows within 30–90 days after the response deadline. (estimate)
- SolicitationCurrentSep 7, 2022
NanoBret Kinase Assay
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N95022Q00552
Archive Date
Sep 14, 2022
Office Address
Bethesda, MD, 20892